Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial-Reference-Cited by-同舟云学术

Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial

Published:2002-11 Issue:3 Volume:54 Page:677-685
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Pollack Alan,Zagars Gunar K,Antolak John A,Kuban Deborah A,Rosen Isaac I

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference46 articles.

1. Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, Stage III, predict long-term survival?;Cox;Int J Radiat Oncol Biol Phys,1983

2. Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy;Zagars;Int J Radiat Oncol Biol Phys,1992

3. Consensus statements on radiation therapy of prostate cancer;J Clin Oncol,1999

4. Postradiotherapy prostate biopsies;Crook;Int J Radiat Oncol Biol Phys,2000

5. Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer;Kavadi;Int J Radiat Oncol Biol Phys,1994

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypofractionated radiation therapy combined with androgen deprivation therapy for high‐risk localized prostate cancer;Journal of Medical Imaging and Radiation Oncology;2024-03-13

2. Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer;Prostate International;2023-09

3. An in-vivo study of the combined therapeutic effects of pulsed non-thermal focused ultrasound and radiation for prostate cancer;International Journal of Radiation Biology;2023-05-19

4. Prostate-specific antigen nadir within 1 year of radiotherapy combined with hormone therapy predicts cancer-specific mortality and biochemical recurrence-free survival in prostate cancer patients;BMC Urology;2022-11-15

5. Longitudinal Changes and Predictive Value of Multiparametric MRI Features for Prostate Cancer Patients Treated with MRI-Guided Lattice Extreme Ablative Dose (LEAD) Boost Radiotherapy;Cancers;2022-09-15